osimertinib
astrazeneca
['adaura']
 with such an unbalanced control arm how could we not have a better os? letting alone that the study was not powered for os!those data don t change too much what we knew about adaura: positive for dfs. does it cure people? i still say unlikely but an option to discuss with pts
Medical Oncologist, department of oncology at the University hospital of Geneva (HUG). All opinions expressed here are my own